+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904896
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Diagnostics Quality Control Market is projected to reach USD 1.72 Billion in 2026. It is expected to continue growing at a CAGR of 5.62%, reaching USD 2.38 Billion by 2032.

In-vitro diagnostics quality control is a mission-critical discipline that safeguards the accuracy, precision, reproducibility, and clinical reliability of laboratory testing. As hospitals, reference laboratories, public health networks, and point-of-care settings expand testing volumes, demand is rising for independent quality control materials, calibrators, proficiency testing, external quality assessment, laboratory information system integration, and standardized quality management practices.

The industry is shaped by internationally recognized requirements such as ISO 15189 for medical laboratories, CLIA requirements in the United States, accreditation practices, EU IVDR obligations, and regulator-led post-market surveillance. These frameworks reinforce the role of IVD quality control in reducing diagnostic error, supporting patient safety, maintaining traceability, and strengthening confidence in clinical decision-making across routine and specialized testing.

Transformative Shifts in the IVD Quality Control Landscape

The IVD quality control landscape is shifting from periodic, manual review toward continuous, risk-based, and digitally connected quality assurance. Laboratories are increasingly managing high-throughput immunoassay, clinical chemistry, hematology, microbiology, coagulation, urinalysis, and molecular diagnostics platforms, which require more sophisticated lot-to-lot verification, peer comparison, internal quality control, and instrument performance monitoring.

Regulatory modernization is also changing supplier and laboratory behavior. The EU IVDR has increased evidence requirements for IVD products, while FDA quality system expectations, global accreditation programs, and post-pandemic investments in diagnostic resilience have elevated demand for traceable, commutable, stable, and assay-relevant QC materials across centralized, near-patient, and decentralized testing environments.

Cumulative Impact of Artificial Intelligence on IVD Quality Control

Artificial intelligence is adding cumulative value across IVD quality control by improving anomaly detection, predictive maintenance, workflow triage, and statistical process monitoring. AI-enabled middleware can analyze Levey-Jennings trends, Westgard rule violations, peer group performance, reagent lot shifts, calibration bias, and instrument drift faster than manual review, helping laboratories intervene before quality failures affect patient results.

The strongest near-term impact is where AI supports, rather than replaces, validated quality management systems. Adoption depends on data integrity, explainability, cybersecurity, documented validation, auditability, and alignment with laboratory accreditation requirements. For QC material suppliers and diagnostic platform providers, AI creates opportunities to differentiate through connected controls, remote monitoring, automated exception management, and evidence-based decision support.

Key Regional Insights for IVD Quality Control

Asia-Pacific is expanding as China, India, Japan, South Korea, ASEAN countries, and Australia invest in healthcare infrastructure, infectious disease testing, oncology diagnostics, chronic disease management, and laboratory accreditation. China’s NMPA oversight, Japan’s PMDA pathway, India’s evolving CDSCO framework, South Korea’s MFDS regulation, and Australia’s NATA-accredited laboratory ecosystem are strengthening the need for reliable IVD quality control across routine and advanced diagnostics.

North America remains a mature, high-compliance region led by the United States and Canada, where CLIA, FDA quality system expectations, accreditation standards, and provincial laboratory requirements support sustained adoption of third-party controls, proficiency testing, and digital QC data management. Europe is being reshaped by IVDR implementation, ISO 15189-based laboratory competence, and stronger performance evidence expectations, while Latin America is led by Brazil and Mexico as laboratories modernize under ANVISA and COFEPRIS influence. The Middle East is advancing through GCC healthcare investment, national screening programs, and hospital accreditation, while Africa’s progress is tied to infectious disease programs, WHO-aligned laboratory quality systems, antimicrobial resistance surveillance, and expanded external quality assessment access.

Key Group Insights Across Global IVD Quality Control Markets

ASEAN markets are strengthening diagnostic quality through laboratory modernization, regional regulatory convergence, expanding universal health coverage initiatives, and growing access to molecular and point-of-care testing. The GCC is prioritizing high-quality hospital networks, national screening programs, medical tourism, and medical laboratory accreditation, creating demand for robust QC materials, proficiency testing, and digital quality systems.

The European Union is defined by IVDR implementation, notified body capacity, post-market performance follow-up, and evidence-based performance expectations, making quality control central to regulatory compliance and market access. BRICS countries combine scale with diverse regulatory maturity, creating opportunities for localized QC production, distributor education, and laboratory training. G7 markets lead in automation, accreditation, advanced diagnostics, and cybersecurity-aware data integration, while NATO countries increasingly view diagnostic readiness, supply security, and interoperable laboratory capacity as components of health system resilience.

Key Country Insights for IVD Quality Control

The United States leads through CLIA-regulated laboratories, FDA oversight, accreditation-driven quality systems, and strong use of third-party controls, proficiency testing, and peer comparison programs. Canada emphasizes provincial quality systems and accredited laboratory practice, while Mexico and Brazil are expanding diagnostic access under COFEPRIS and ANVISA oversight. In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing through ISO-aligned laboratory practices, national accreditation structures, and IVDR-influenced product requirements, while Russia maintains demand across hospital, regional, and public-sector diagnostic networks.

China is scaling domestic IVD manufacturing, hospital laboratory capacity, and NMPA-regulated diagnostic quality expectations; India is expanding diagnostics through public health programs and private laboratory networks; and Japan prioritizes precision, automation, quality assurance, and testing needs linked to an aging population. Australia maintains rigorous accreditation through NATA-linked systems and strong external quality assessment participation, while South Korea continues to grow through advanced diagnostics, export-oriented IVD manufacturing, digital health infrastructure, and technologically mature clinical laboratories.

Actionable Recommendations for IVD Quality Control Leaders

Industry leaders should prioritize commutable, matrix-appropriate, stable, and clinically relevant quality control materials that perform across multi-vendor testing platforms and diverse assay methodologies. Investment in lot-to-lot verification support, stability documentation, traceability, value assignment, uncertainty communication, and regulatory-ready technical files will improve competitiveness as laboratories demand higher confidence in QC performance.

Organizations should also build digital ecosystems around QC data, including peer comparison, middleware integration, automated rule monitoring, audit-ready reporting, and secure cloud-based analytics. Strategic partnerships with accredited laboratories, reference institutions, public health programs, and regional distributors can accelerate adoption, while training programs in ISO 15189, Westgard rules, risk-based quality management, and external quality assessment can strengthen customer retention and operational credibility.

Research Methodology for IVD Quality Control Analysis

This executive summary is based on a structured review of verified industry, regulatory, and clinical laboratory sources, including international laboratory standards, publicly available regulator guidance, accreditation frameworks, and established quality management practices in medical testing. The analysis considers product categories such as independent controls, calibrators, data management tools, proficiency testing, external quality assessment, and quality assurance services.

Regional and country insights were developed by evaluating regulatory maturity, healthcare infrastructure, diagnostic testing demand, laboratory accreditation adoption, public health investment, and adoption of automated and molecular diagnostic technologies. The methodology emphasizes data-backed interpretation, cross-source validation, and practical relevance for manufacturers, laboratories, distributors, healthcare providers, and investors operating in the IVD quality control ecosystem.

Conclusion: Quality Control as the Foundation of Reliable Diagnostics

In-vitro diagnostics quality control is becoming more strategic as laboratories face rising test complexity, stricter regulatory expectations, workforce constraints, and growing pressure to deliver accurate results at scale. The industry’s direction will be shaped by independent QC adoption, digital quality management, AI-supported monitoring, traceable materials, and broader use of proficiency testing and external quality assessment.

Organizations that combine scientifically robust QC materials with connected analytics, regulatory readiness, technical education, and regional expertise will be best positioned to grow responsibly. As diagnostic testing expands across centralized laboratories, decentralized care, public health networks, and point-of-care environments, quality control will remain essential to patient safety, clinical confidence, and sustainable IVD development.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Quality-System and Compliance Requirements
4.3.1.2. Increasing Test-Menu Complexity
4.3.1.3. Independent Assessment and Peer Benchmarking
4.3.1.4. Decentralized Testing and Digital Oversight
4.3.2. Key Restraints
4.3.2.1. Budget Pressure and Procurement Consolidation
4.3.2.2. Fragmented Regulatory and Market-Access Requirements
4.3.2.3. Laboratory Workflow and Staffing Burden
4.3.2.4. Installed-Platform Dependence
4.3.3. Key Opportunities
4.3.3.1. Performance-Verification Materials
4.3.3.2. Connected QC and Peer-Data Services
4.3.3.3. Molecular Controls and Format Innovation
4.3.3.4. Asia-Pacific Expansion and OEM Partnerships
4.3.4. Key Challenges
4.3.4.1. Cross-Platform Performance Credibility
4.3.4.2. Data Interoperability and Governance
4.3.4.3. Distributor Technical Enablement
4.3.4.4. Supply and Lot-Transition Continuity
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Diagnostics Quality Control Market, by Offering
7.1. Introduction
7.2. Quality Control Materials
7.2.1. Routine Monitoring Controls
7.2.2. Performance Verification Materials
7.3. QC Software and Data Services
7.3.1. QC Data Management Software
7.3.2. Peer Comparison Services
8. In-Vitro Diagnostics Quality Control Market, by Material Format
8.1. Introduction
8.2. Liquid-Stable
8.3. Lyophilized
8.4. Frozen
8.5. Dried Carrier
9. In-Vitro Diagnostics Quality Control Market, by Analyte Coverage
9.1. Introduction
9.2. Multi-Analyte
9.3. Single-Analyte
10. In-Vitro Diagnostics Quality Control Market, by Value Assignment
10.1. Introduction
10.2. Assigned Controls
10.2.1. Quantitative Values and Ranges
10.2.2. Qualitative Expected Results
10.3. Unassayed Controls
11. In-Vitro Diagnostics Quality Control Market, by Supplier Independence
11.1. Introduction
11.2. Independent Third-Party
11.3. Manufacturer-Specific
12. In-Vitro Diagnostics Quality Control Market, by Control Purpose
12.1. Introduction
12.2. Routine Performance Monitoring
12.3. Calibration Verification and Linearity
12.4. Method and Change Verification
12.5. Interlaboratory Benchmarking
13. In-Vitro Diagnostics Quality Control Market, by Testing Discipline
13.1. Introduction
13.2. Chemistry and Immunoanalysis
13.2.1. Clinical Chemistry
13.2.2. Immunoassay and Serology
13.2.3. Blood Gas and Critical Care
13.2.4. Toxicology and Therapeutic Drug Monitoring
13.2.5. Urinalysis and Body Fluids
13.3. Microbiology, Molecular, and Genetic Testing
13.3.1. Molecular Diagnostics and Genetics
13.3.2. Clinical Microbiology
13.4. Hematology and Cellular Analysis
13.4.1. Hematology
13.4.2. Hemostasis
13.4.3. Flow Cytometry
13.4.4. Andrology
13.5. Immunohematology
13.6. Anatomic Pathology
14. In-Vitro Diagnostics Quality Control Market, by Buyer Type
14.1. Introduction
14.2. Clinical Testing Providers
14.2.1. Hospital and Health-System Laboratories
14.2.2. Independent Laboratories
14.2.3. Ambulatory and Decentralized Testing Sites
14.2.4. Blood Centers and Transfusion Services
14.2.5. Public Health Laboratories
14.3. IVD Manufacturers
14.4. Home Self-Testing Users
15. In-Vitro Diagnostics Quality Control Market, by Sales Channel
15.1. Introduction
15.2. Direct Sales
15.3. Distributor and Reseller Sales
15.4. OEM and Private-Label Supply
16. In-Vitro Diagnostics Quality Control Market, by Region
16.1. Introduction
16.2. North America
16.3. Europe
16.4. Asia-Pacific
16.5. Latin America
16.6. Middle East
16.7. Africa
17. In-Vitro Diagnostics Quality Control Market, by Group
17.1. Introduction
17.2. NATO
17.3. G7
17.4. European Union
17.5. BRICS
17.6. ASEAN
17.7. GCC
18. In-Vitro Diagnostics Quality Control Market, by Country
18.1. Introduction
18.2. United States
18.3. China
18.4. Germany
18.5. Japan
18.6. France
18.7. United Kingdom
18.8. Canada
18.9. Italy
18.10. Australia
18.11. South Korea
18.12. India
18.13. Spain
18.14. Brazil
18.15. Russia
18.16. Mexico
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Bio-Rad Laboratories, Inc.
20.2. Thermo Fisher Scientific Inc.
20.3. Randox Laboratories
20.4. LGC Group
20.5. Bio-Techne Corporation
20.6. Streck, LLC
20.7. Sysmex Corporation
20.8. Beckman Coulter
20.9. Siemens Healthineers AG
20.10. Roche Diagnostics
20.11. Abbott Laboratories
20.12. Antylia Scientific
20.13. Microbiologics, Inc.
20.14. Fortress Diagnostics
20.15. SERO AS
20.16. Eurotrol
20.17. Quantimetrix Corporation
20.18. Maine Molecular Quality Controls, Inc.
20.19. UTAK Laboratories, Inc.
20.20. DiaSys Diagnostic Systems GmbH
20.21. SPINREACT, S.A.U.
20.22. DIAGON Ltd.
20.23. PZ CORMAY S.A.
20.24. Liofilchem S.r.l.
20.25. ARCHEM Saglik Sanayi ve Ticaret A.S.
20.26. Agappe Diagnostics Limited
20.27. Mindray
20.28. Beijing Controls & Standards Biotechnology Co., Ltd.
20.29. Autobio Diagnostics Co., Ltd.
20.30. SEKISUI Diagnostics, LLC
20.31. Labtest Diagnóstica S.A.
20.32. AUDIT MicroControls, Inc.
20.33. VERICHEM Laboratories, Inc.
20.34. Microbix Biosystems Inc.
20.35. Precision BioLogic Inc.
20.36. Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
20.37. Vircell, S.L.
20.38. HORIBA ABX SAS
20.39. Werfen
20.40. Diagnostica Stago, S.A.S.
20.41. Sentinel Diagnostics
20.42. Advanced Instruments
20.43. Becton, Dickinson and Company
20.44. TRINA BIOREACTIVES AG
20.45. HUMAN Diagnostics
21. Key Experts
List of Figures
FIGURE 1. Global In-Vitro Diagnostics Quality Control Market, Years Considered for the Study
FIGURE 2. Global In-Vitro Diagnostics Quality Control Market, Research Design
FIGURE 3. Global In-Vitro Diagnostics Quality Control Market, Research Framework
FIGURE 4. Global In-Vitro Diagnostics Quality Control Market, Data Triangulation
FIGURE 5. Global In-Vitro Diagnostics Quality Control Market Size, 2017-2032 (USD Million)
FIGURE 6. Global In-Vitro Diagnostics Quality Control Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global In-Vitro Diagnostics Quality Control Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2025 vs 2032 (%)
FIGURE 9. Global In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2025 vs 2032 (%)
FIGURE 11. Global In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2025 vs 2032 (%)
FIGURE 13. Global In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2025 vs 2032 (%)
FIGURE 15. Global In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2025 vs 2032 (%)
FIGURE 17. Global In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2025 vs 2032 (%)
FIGURE 19. Global In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2025 vs 2032 (%)
FIGURE 21. Global In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 23. Global In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global In-Vitro Diagnostics Quality Control Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global In-Vitro Diagnostics Quality Control Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global In-Vitro Diagnostics Quality Control Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global In-Vitro Diagnostics Quality Control Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global In-Vitro Diagnostics Quality Control Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global In-Vitro Diagnostics Quality Control Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global In-Vitro Diagnostics Quality Control Market Segmentation & Coverage
TABLE 2. Global In-Vitro Diagnostics Quality Control Market Size, 2017-2032 (USD Million)
TABLE 3. Global In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Quality Control Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Quality Control Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Quality Control Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Routine Monitoring Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Routine Monitoring Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Routine Monitoring Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Performance Verification Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Performance Verification Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Performance Verification Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global QC Software and Data Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global QC Software and Data Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global QC Software and Data Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global QC Data Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global QC Data Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global QC Data Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Peer Comparison Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Peer Comparison Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Peer Comparison Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 23. Global Liquid-Stable Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Liquid-Stable Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Liquid-Stable Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Frozen Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Frozen Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Frozen Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Dried Carrier Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Dried Carrier Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Dried Carrier Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 36. Global Multi-Analyte Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Multi-Analyte Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Multi-Analyte Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Single-Analyte Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Single-Analyte Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Single-Analyte Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 43. Global Assigned Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Assigned Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Assigned Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Quantitative Values and Ranges Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Quantitative Values and Ranges Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Quantitative Values and Ranges Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Qualitative Expected Results Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Qualitative Expected Results Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Qualitative Expected Results Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Unassayed Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Unassayed Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Unassayed Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 56. Global Independent Third-Party Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Independent Third-Party Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Independent Third-Party Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Manufacturer-Specific Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Manufacturer-Specific Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Manufacturer-Specific Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 63. Global Routine Performance Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Routine Performance Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Routine Performance Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Calibration Verification and Linearity Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Calibration Verification and Linearity Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Calibration Verification and Linearity Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Method and Change Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Method and Change Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Method and Change Verification Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Interlaboratory Benchmarking Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Interlaboratory Benchmarking Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Interlaboratory Benchmarking Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 76. Global Chemistry and Immunoanalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Chemistry and Immunoanalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Chemistry and Immunoanalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Clinical Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Clinical Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Clinical Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Immunoassay and Serology Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Immunoassay and Serology Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Immunoassay and Serology Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Blood Gas and Critical Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Blood Gas and Critical Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Blood Gas and Critical Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Toxicology and Therapeutic Drug Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Toxicology and Therapeutic Drug Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Toxicology and Therapeutic Drug Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Urinalysis and Body Fluids Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Urinalysis and Body Fluids Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Urinalysis and Body Fluids Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Microbiology, Molecular, and Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Microbiology, Molecular, and Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Microbiology, Molecular, and Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Molecular Diagnostics and Genetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Molecular Diagnostics and Genetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Molecular Diagnostics and Genetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Clinical Microbiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Clinical Microbiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Clinical Microbiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Hematology and Cellular Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Hematology and Cellular Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Hematology and Cellular Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Hematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Hematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Hematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Hemostasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Hemostasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Hemostasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Andrology Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Andrology Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Andrology Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Immunohematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Immunohematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Immunohematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Anatomic Pathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 125. Global Clinical Testing Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Clinical Testing Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Clinical Testing Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Hospital and Health-System Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Hospital and Health-System Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Hospital and Health-System Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Independent Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Independent Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Independent Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Ambulatory and Decentralized Testing Sites Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Ambulatory and Decentralized Testing Sites Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Ambulatory and Decentralized Testing Sites Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Blood Centers and Transfusion Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Blood Centers and Transfusion Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Blood Centers and Transfusion Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Public Health Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Public Health Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Public Health Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global IVD Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global IVD Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global IVD Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Home Self-Testing Users Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Home Self-Testing Users Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Home Self-Testing Users Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 150. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Distributor and Reseller Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Distributor and Reseller Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Distributor and Reseller Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global OEM and Private-Label Supply Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global OEM and Private-Label Supply Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global OEM and Private-Label Supply Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. North America In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. North America In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 162. North America In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 163. North America In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 164. North America In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 165. North America In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 166. North America In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 167. North America In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 168. North America In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 169. North America In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 170. North America In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 171. North America In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 172. North America In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 173. North America In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 174. North America In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 175. North America In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 176. North America In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 177. Europe In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Europe In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 179. Europe In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 180. Europe In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 181. Europe In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 182. Europe In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 183. Europe In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 184. Europe In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 185. Europe In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 186. Europe In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 187. Europe In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 188. Europe In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 189. Europe In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 190. Europe In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 191. Europe In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 192. Europe In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 193. Europe In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 210. Asia-Pacific In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 211. Latin America In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Latin America In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 213. Latin America In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 214. Latin America In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 215. Latin America In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 216. Latin America In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 217. Latin America In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 218. Latin America In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 219. Latin America In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 220. Latin America In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 221. Latin America In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 222. Latin America In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 223. Latin America In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 224. Latin America In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 225. Latin America In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 226. Latin America In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 227. Latin America In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 228. Middle East In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 229. Middle East In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 230. Middle East In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 231. Middle East In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 232. Middle East In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 233. Middle East In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 234. Middle East In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 235. Middle East In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 236. Middle East In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 237. Middle East In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 238. Middle East In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 239. Middle East In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 240. Middle East In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 241. Middle East In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 242. Middle East In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 243. Middle East In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 244. Middle East In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 245. Africa In-Vitro Diagnostics Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 246. Africa In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 247. Africa In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 248. Africa In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 249. Africa In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 250. Africa In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 251. Africa In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 252. Africa In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 253. Africa In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 254. Africa In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 255. Africa In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 256. Africa In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 257. Africa In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 258. Africa In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 259. Africa In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 260. Africa In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 261. Africa In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 262. Global In-Vitro Diagnostics Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. NATO In-Vitro Diagnostics Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 264. NATO In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 265. NATO In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 266. NATO In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 267. NATO In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 268. NATO In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 269. NATO In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 270. NATO In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 271. NATO In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 272. NATO In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 273. NATO In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 274. NATO In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 275. NATO In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 276. NATO In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 277. NATO In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 278. NATO In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 279. NATO In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 280. G7 In-Vitro Diagnostics Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 281. G7 In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 282. G7 In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 283. G7 In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 284. G7 In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 285. G7 In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 286. G7 In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 287. G7 In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 288. G7 In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 289. G7 In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 290. G7 In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 291. G7 In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 292. G7 In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 293. G7 In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 294. G7 In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 295. G7 In-Vitro Diagnostics Quality Control Market Size, by Clinical Testing Providers, 2017-2032 (USD Million)
TABLE 296. G7 In-Vitro Diagnostics Quality Control Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 297. European Union In-Vitro Diagnostics Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 298. European Union In-Vitro Diagnostics Quality Control Market Size, by Offering, 2017-2032 (USD Million)
TABLE 299. European Union In-Vitro Diagnostics Quality Control Market Size, by Quality Control Materials, 2017-2032 (USD Million)
TABLE 300. European Union In-Vitro Diagnostics Quality Control Market Size, by QC Software and Data Services, 2017-2032 (USD Million)
TABLE 301. European Union In-Vitro Diagnostics Quality Control Market Size, by Material Format, 2017-2032 (USD Million)
TABLE 302. European Union In-Vitro Diagnostics Quality Control Market Size, by Analyte Coverage, 2017-2032 (USD Million)
TABLE 303. European Union In-Vitro Diagnostics Quality Control Market Size, by Value Assignment, 2017-2032 (USD Million)
TABLE 304. European Union In-Vitro Diagnostics Quality Control Market Size, by Assigned Controls, 2017-2032 (USD Million)
TABLE 305. European Union In-Vitro Diagnostics Quality Control Market Size, by Supplier Independence, 2017-2032 (USD Million)
TABLE 306. European Union In-Vitro Diagnostics Quality Control Market Size, by Control Purpose, 2017-2032 (USD Million)
TABLE 307. European Union In-Vitro Diagnostics Quality Control Market Size, by Testing Discipline, 2017-2032 (USD Million)
TABLE 308. European Union In-Vitro Diagnostics Quality Control Market Size, by Chemistry and Immunoanalysis, 2017-2032 (USD Million)
TABLE 309. European Union In-Vitro Diagnostics Quality Control Market Size, by Microbiology, Molecular, and Genetic Testing, 2017-2032 (USD Million)
TABLE 310. European Union In-Vitro Diagnostics Quality Control Market Size, by Hematology and Cellular Analysis, 2017-2032 (USD Million)
TABLE 311. European Union In-Vitro Diagnostics Quality Control Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories
  • LGC Group
  • Bio-Techne Corporation
  • Streck, LLC
  • Sysmex Corporation
  • Beckman Coulter
  • Siemens Healthineers AG
  • Roche Diagnostics
  • Abbott Laboratories
  • Antylia Scientific
  • Microbiologics, Inc.
  • Fortress Diagnostics
  • SERO AS
  • Eurotrol
  • Quantimetrix Corporation
  • Maine Molecular Quality Controls, Inc.
  • UTAK Laboratories, Inc.
  • DiaSys Diagnostic Systems GmbH
  • SPINREACT, S.A.U.
  • DIAGON Ltd.
  • PZ CORMAY S.A.
  • Liofilchem S.r.l.
  • ARCHEM Sağlık Sanayi ve Ticaret A.Ş.
  • Agappe Diagnostics Limited
  • Mindray
  • Beijing Controls & Standards Biotechnology Co., Ltd.
  • Autobio Diagnostics Co., Ltd.
  • SEKISUI Diagnostics, LLC
  • Labtest Diagnóstica S.A.
  • AUDIT MicroControls, Inc.
  • VERICHEM Laboratories, Inc.
  • Microbix Biosystems Inc.
  • Precision BioLogic Inc.
  • Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
  • Vircell, S.L.
  • HORIBA ABX SAS
  • Werfen
  • Diagnostica Stago, S.A.S.
  • Sentinel Diagnostics
  • Advanced Instruments
  • Becton, Dickinson and Company
  • TRINA BIOREACTIVES AG
  • HUMAN Diagnostics

Table Information

Report AttributeDetails
No. of Pages186
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.38 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned45

Related Topics

Related Reports

In-Vitro Diagnostics Quality Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

In-Vitro Diagnostics Quality Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
In-Vitro Diagnostics Quality Control Market Outlook 2026-2034: Market Share, and Growth Analysis by Products & Services (Quality Control Products, Data Management Solutions, Quality Assurance Services), Application, End User - Product Image

In-Vitro Diagnostics Quality Control Market Outlook 2026-2034: Market Share, and Growth Analysis by Products & Services (Quality Control Products, Data Management Solutions, Quality Assurance Services), Application, End User

  • Report
  • 160 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030 - Product Image

In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030

  • Report
  • 379 Pages
  • Global
From
In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides - Product Image

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

  • Report
  • 372 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.